Jilin Longtai Pharmaceutical

Jilin Longtai Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of both Traditional Chinese Medicine (TCM) and chemical drugs. Headquartered in Meihekou, Jilin Province, the company operates multiple GMP-certified production lines for various dosage forms including capsules, tablets, and granules. Its product portfolio primarily targets cardiovascular and cerebrovascular health, respiratory ailments, and digestive disorders. Longtai is recognized as a high-tech enterprise in Jilin and is listed on the National Equities Exchange and Quotations (NEEQ) under the symbol 831920. The company emphasizes a "quality first" approach to drug manufacturing and distribution within the Chinese domestic market. Key products include Compound Danshen Tablets and Ginkgo Biloba Extract, which are widely used in clinical practice in China.